These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, Schiepers C, Herrmann K. Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034 [Abstract] [Full Text] [Related]
3. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287 [Abstract] [Full Text] [Related]
4. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results. Demir Ö, Köse N, Özkan E, Ünlütürk U, Aras G, Erdoğan MF. Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467 [Abstract] [Full Text] [Related]
5. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK. Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537 [Abstract] [Full Text] [Related]
9. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S. Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [Abstract] [Full Text] [Related]
10. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT). Familiar C, Merino S, Valhondo R, López C, Pérez X, De Los Monteros PE, Hernández F, Pazos M, Pallarés R, Pascual AC. Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900 [Abstract] [Full Text] [Related]